Biosensor as well as preparation method and application thereof

Through surface blotting hydrogel technology and enzyme-mediated organic-inorganic hybrid nanoflower technology, the low mass transfer efficiency and enzyme leakage of enzymes in biosensors are solved, and the stability and adaptability of AChE are improved. The ability to efficiently identify AChE inhibitors is achieved.

CN118956855APending Publication Date: 2024-11-15CHINA UNIV OF PETROLEUM (EAST CHINA)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411092545.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing biosensors have limited mass transfer efficiency and enzyme leakage due to the enzyme immobilization method, which limits their application scope, especially in complex or extreme environments.

Method used

The surface blotting hydrogel technology is used to combine substrate shielding technology, magnetic bead templates and Strep-Tag system to form specific blots on the hydrogel surface, providing specific multivalent binding sites for acetylcholinesterase (AChE) and through enzymes Mediated organic-inorganic hybrid nanoflower technology enhances the specific surface area of ​​the enzyme to the substrate and the activity and stability of the enzyme.

Benefits of technology

It significantly improves the accessibility and stability of AChE, solves the problems of low mass transfer efficiency and enzyme leakage, and enhances the adaptability and reusability of biosensors in complex environments.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956855A_ABST
    Figure CN118956855A_ABST
Patent Text Reader

Abstract

The invention discloses a biosensor as well as a preparation method and application thereof, and belongs to the technical field of biosensor construction. According to the technical scheme, the preparation method comprises a step of preparing STMB / Strep-tag II / hydrogel and a step of preparing Strep-tag II / imprinting hydrogel. The step of preparing the STMB / Strep-tag II / hydrogel further comprises the following steps: dropwise adding MAA / Strep-tag II / STMBs suspension liquid into a cell culture plate hole, then adding ultrapure water, uniformly shaking to enable the MAA / Strep-tag II / STMBs to be uniformly and stably distributed at the bottom of the hole, fixing a magnet below the plate hole, fixing the MAA / Strep-tag II / STMBs at the bottom of the hole by utilizing magnetic adsorption force, enabling the surface of part of the MAA / Strep-tag II / STMBs to be shielded by a substrate at the bottom of the hole, and finally preparing the MAA / Strep-tag II / STMBs hydrogel. And a water layer is formed above the MAA / Strep-tag II / STMBs (Methacrylic Acid / Strep-tag II / STMBs). The method is applied to the aspect of detecting the AChE inhibitor, the technical problem that the application range of an existing biosensor is limited due to limited mass transfer efficiency and enzyme leakage in an enzyme immobilization mode is solved, the AChE inhibitor can be efficiently recognized, and the activity and stability of the enzyme are greatly improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biosensor construction, and in particular relates to a biosensor, a preparation method and application thereof. Background Art

[0002] Alzheimer's disease is increasingly becoming a major global health challenge, and the research and development of its treatment strategies has become extremely urgent. Among the many potential treatments, acetylcholinesterase (AChE) inhibitors have attracted much attention due to their unique mechanism: they can effectively slow down the decomposition of acetylcholine, thereby increasing the concentration of acetylcholine in the brain and directly promoting the improvement of patients' cognitive functions. More importantly, given the close connection between AChE and Aβ (β-amyloid protein) metabolism, AChE inhibitors may also indirectly delay the pathological progression of Alzheimer's disease by reducing the generation of Aβ or accelerating its clearance. Therefore, AChE inhibitors have become a very promising screening direction in the field of drug research and development.

[0003] Biosensors have shown significant advantages in real-time detection and high-throughput screening due to their high specificity, excellent sensitivity and rapid response. However, it is worth noting that the performance of enzyme biosensors depends largely on the enzyme immobilization technology used.

[0004] Enzyme immobilization technology significantly improves the stability, reusability and ease of operation of enzymes by firmly anchoring enzyme molecules on specific carriers. Hydrogels are considered ideal enzyme immobilization carriers due to their excellent biocompatibility and high water content. However, encapsulation, as a commonly used immobilization method for hydrogels, may lead to limited mass transfer efficiency, thereby affecting the effective interaction between substrates and enzymes; the problem of enzyme leakage cannot be ignored, as it may weaken the immobilization effect and reduce the utilization efficiency of the enzyme; at the same time, insufficient environmental stability also limits the application potential of hydrogel-immobilized enzymes in complex or extreme environments. Summary of the invention

[0005] In view of the shortcomings of the prior art, the technical problem to be solved by the present invention is to overcome the technical problem that the existing biosensors have limited mass transfer efficiency and enzyme leakage due to the enzyme immobilization method, which limits their application scope. A biosensor that can efficiently identify AChE inhibitors and greatly improve the activity and stability of the enzyme, as well as its preparation method and application are proposed.

[0006] In order to solve the technical problem, the technical solution adopted by the present invention is:

[0007] In one aspect, the present invention provides a method for preparing a biosensor, comprising a STMB / Strep-tag II / hydrogel preparation step, and a Strep-tag II / imprinted hydrogel preparation step;

[0008] The STMB / Strep-tag II / hydrogel preparation step further comprises:

[0009] Take the MAA / Strep-tag II / STMBs suspension and drop it into the well of the cell culture plate, then add ultrapure water, shake well to make the MAA / Strep-tag II / STMBs evenly and stably distributed at the bottom of the well, fix a magnet under the well, and use magnetic adsorption force to fix the MAA / Strep-tag II / STMBs at the bottom of the well, so that part of the surface of the MAA / Strep-tag II / STMBs is shielded by the bottom substrate of the well, and a water layer is formed above the MAA / Strep-tag II / STMBs;

[0010] Dissolve acrylamide, N,N'-methylenebisacrylamide and α,α'-azobisisobutylamidine dihydrochloride in ultrapure water, stir evenly to obtain a polymerization raw material solution, and slowly drop the polymerization raw material solution into the wells of the cell culture plate;

[0011] The wells of the cell culture plate are placed in an environment of 50-55° C. and incubated for 20-30 minutes to form a hydrogel complex. After the hydrogel complex is completely formed, the magnet is gently removed, and the hydrogel complex is peeled off from the cell culture plate. The peeled hydrogel complex is immersed in ultrapure water to fully swell to the maximum volume to obtain STMB / Strep-tag II / hydrogel;

[0012] The preparation steps of the Strep-tag II / imprinted hydrogel further include: placing the STMB / Strep-tag II / hydrogel into a solution containing desthiobiotin, incubating with shaking, and collecting the STMBs in the solution using magnetic separation technology, leaving a hydrogel with Strep-Tag II sites imprinted on the surface, namely, Strep-Tag II / imprinted hydrogel.

[0013] Preferably, the method further comprises a step of preparing the MAA / Strep-tag II / STMBs;

[0014] The MAA / Strep-tag II / STMBs preparation step further includes: mixing the pretreated magnetic bead-coated STMBs with the Strep-tag II solution to obtain Strep-tag II / STMB, adding methacrylamide to the Strep-tag II / STMB, and mixing to obtain MAA / Strep-tag II / STMBs.

[0015] Preferably, the N-terminus of Strep-tag II is modified with Maleimide; the sequence of the Strep-tag II is: Maleimide-Trp-Ser-His-Pro-Gln-Phe-Glu-Lys.

[0016] Preferably, the treated magnetic bead-coated STMBs are pretreated by the following method: taking Strep-Tactin-coated magnetic beads STMBs, washing them with a binding buffer containing Tris-HCl, NaCl, EDTA and a pH value of 8.0 to complete the pretreatment; the particle size of the magnetic bead-coated STMBs is 30-150 μm, the ligand content is 6 mg Strep-Tactin / mL gel, and the protein binding amount is 7 Strep-tag II protein / mL gel.

[0017] Preferably, the method further comprises the step of preparing Apt / Strep-tag II / imprinted hydrogel, wherein the step of preparing Apt / Strep-tag II / imprinted hydrogel further comprises: applying a mixture containing 1-ethyl-(3-dimethylaminopropyl) carbodiimide, N-hydroxysuccinimide, and 30-50 nmol / L of an AChE-specific binding aptamer to the surface of the Strep-tag II / hydrogel, followed by incubation, and allowing the AChE-specific binding aptamer to specifically bind to the Strep-tag II site through a carboxyl-amine condensation reaction to obtain the Apt / Strep-tag II / imprinted hydrogel.

[0018] Preferably, the method further includes the step of preparing AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel, and the step of preparing AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel further includes: immersing the Apt / Strep-tag II / imprinted hydrogel in a mixed solution containing PBS, AChE solution and copper sulfate solution, and incubating to obtain the AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel, i.e., the biosensor.

[0019] Preferably, the sequence of the AChE-specific binding aptamer is:

[0020] 5′-NH2-TTTTT TTTTT TT GGTTG ACTGT AGCTC TGGCA GACGT AGTGT GAAGG TACC-3′.

[0021] Another aspect of the present invention provides a biosensor prepared by the biosensor described in any of the above technical solutions.

[0022] The present invention also provides the use of the above biosensor in detecting AChE inhibitors, including:

[0023] Acetylthiocholine chloride was used as the specific substrate of AChE and oxidized 3,3',5,5'-tetramethylbenzidine was used as a color indicator to detect AChE inhibitors.

[0024] Preferably, an activation process is also included: after the measurement is completed, the AChE-Cu3(PO4)2HNF / Apt / Strep-tagII / imprinted hydrogel is immersed in an acetylthiocholine chloride substrate solution, incubated at room temperature, and washed with ultrapure water to complete the activation.

[0025] Compared with the prior art, the present invention has the following beneficial effects:

[0026] The present invention provides a method for preparing a biosensor, which utilizes surface imprinted hydrogel technology. The core of this strategy is to integrate substrate shielding technology, magnetic bead templates and Strep-Tag system to form specific imprints on the hydrogel surface, provide specific multivalent binding sites for acetylcholinesterase (AChE), and ensure high affinity interaction with AChE. These specific aptamers are fully exposed on the hydrogel surface, effectively improving the accessibility of AChE and successfully solving the mass transfer problem. In addition, the present invention also combines enzyme-mediated organic-inorganic hybrid nanoflower technology, which not only significantly increases the contact specific surface area between the enzyme and the substrate, but also greatly improves the activity and stability of the enzyme, effectively solving the problems of enzyme leakage and environmental adaptability. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 This is a scanning electron microscope image of the hydrogel prepared under the condition of additional addition of ultrapure water provided in Example 1 of the present invention;

[0028] Figure 2 This is a scanning electron microscope image of the hydrogel prepared without adding ultrapure water provided in Example 1 of the present invention;

[0029] Figure 3 This is a scanning electron microscope characterization image of the Strep-Tag II / imprinted hydrogel provided in Example 1 of the present invention;

[0030] Figure 4 This is a scanning electron microscope characterization image of the HNF / Apt / Strep-tag II / imprinted hydrogel prepared when the Apt concentration provided in Example 1 of the present invention is 20 nmol / L;

[0031] Figure 5 This is a scanning electron microscope characterization image of the HNF / Apt / Strep-tag II / imprinted hydrogel prepared when the Apt concentration provided in Example 1 of the present invention is 30 nmol / L;

[0032] Figure 6 This is a scanning electron microscope characterization image of the HNF / Apt / Strep-tag II / imprinted hydrogel prepared when the Apt concentration provided in Example 1 of the present invention is 40 nmol / L;

[0033] Figure 7 This is a scanning electron microscope characterization image of the HNF / Apt / Strep-tag II / imprinted hydrogel prepared when the Apt concentration provided in Example 1 of the present invention is 50 nmol / L;

[0034] Figure 8 Schematic diagram of the response of AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel to different concentrations of galanthamine provided by the embodiment of the present invention: 0, 10nmol / L, 100nmol / L, 300nmol / L, 500nmol / L, 700nmol / L, 1μmol / L, 10μmol / L, 100μmol / L and 1mmol / L;

[0035] Fig. 9 The relationship between the inhibition rate and the logarithm of the galanthamine concentration measured by the colorimetric method provided in the embodiment of the present invention is shown in the inset. 50 Schematic diagram of linear regression analysis of values;

[0036] Fig.10 This is the repeated use effect of the AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel provided in the embodiment of the present invention. DETAILED DESCRIPTION

[0037] The technical scheme in the specific embodiment of the present invention will be described in detail and completely in conjunction with the accompanying drawings. Obviously, the described embodiments are only some specific implementation methods of the overall technical scheme of the present invention, rather than all implementation methods. Based on the overall concept of the present invention, all other embodiments obtained by ordinary technicians in this field fall within the scope of protection of the present invention.

[0038] In one aspect, the present invention provides a method for preparing a biosensor, comprising a STMB / Strep-tag II / hydrogel preparation step, and a Strep-tag II / imprinted hydrogel preparation step;

[0039] The STMB / Strep-tag II / hydrogel preparation step further comprises:

[0040] Take the MAA / Strep-tag II / STMBs suspension and drop it into the well of the cell culture plate, then add ultrapure water, shake well to make the MAA / Strep-tag II / STMBs evenly and stably distributed at the bottom of the well, fix a magnet under the well, and use magnetic adsorption force to fix the MAA / Strep-tag II / STMBs at the bottom of the well, so that part of the surface of the MAA / Strep-tag II / STMBs is shielded by the bottom substrate of the well, and a water layer is formed above the MAA / Strep-tag II / STMBs;

[0041] Dissolve acrylamide, N,N'-methylenebisacrylamide and α,α'-azobisisobutylamidine dihydrochloride in ultrapure water, stir evenly to obtain a polymerization raw material solution, and slowly drop the polymerization raw material solution into the wells of the cell culture plate;

[0042] The wells of the cell culture plate are placed in an environment of 50-55° C. and incubated for 20-30 minutes to form a hydrogel complex. After the hydrogel complex is fully formed, the magnet is gently removed, and the hydrogel complex is peeled off from the cell culture plate. The peeled hydrogel complex is immersed in ultrapure water to fully swell to the maximum volume to obtain STMB / Strep-tag II / hydrogel. In this process, the components in the raw material solution undergo free radical polymerization under the catalysis of AIBD (α, α'-azobisisobutyramidine dihydrochloride), and MBAA (N, N'-methylenebisacrylamide) is used as a cross-linking agent to promote the formation of the hydrogel.

[0043] The preparation steps of the Strep-tag II / imprinted hydrogel further include: placing the STMB / Strep-tag II / hydrogel into a solution containing desthiobiotin, incubating with shaking, and collecting the STMBs in the solution using magnetic separation technology, leaving a hydrogel with Strep-Tag II sites imprinted on the surface, namely, Strep-Tag II / imprinted hydrogel.

[0044] The above-mentioned STMB / Strep-tag II / hydrogel preparation steps define the addition of ultrapure water after adding the MAA / Strep-tag II / STMBs suspension to the wells of the cell culture plate. The reason is that the primary function of the additional addition of ultrapure water is to ensure that the liquid fully covers the bottom of the well, promotes the uniform distribution of the magnetic beads in the wells, and avoids aggregation. Secondly, and more importantly, when the magnetic beads are fixed to the bottom of the wells by the action of a magnet, a layer of water naturally forms above them. This layer of water plays a key interfacial isolation role when the subsequent raw material liquid is added, so that the raw material liquid does not directly touch the exposed surface of the magnetic beads, but first penetrates the water layer and contacts the magnetic beads in a progressive manner, thereby achieving a sustained release effect of the raw material. This mechanism of action helps to form a hydrogel layer with moderate hardness on the surface of the magnetic beads, creating favorable conditions for the subsequent easy elution of the magnetic beads from the hydrogel and the formation of surface imprints.

[0045] To verify the effectiveness of this technique, we compared the scanning electron microscopy images of STMB / Strep-tag II / hydrogels prepared with and without the addition of ultrapure water (e.g. Figure 1 As shown). The results show that when ultrapure water is added, the hydrogel structure becomes looser, the pore size increases significantly, and the magnetic beads are clearly visible and mainly distributed on the surface of the hydrogel. This structure greatly facilitates the subsequent magnetic bead elution process and the formation of surface imprints. On the contrary, if ultrapure water is not added, the hydrogel structure is compact, the pore size decreases, and the magnetic beads are deeply embedded in it, with only a small amount of surface exposed, which makes the subsequent magnetic bead elution more difficult.

[0046] In a preferred embodiment, the method further comprises a step of preparing the MAA / Strep-tag II / STMBs to obtain the MAA / Strep-tag II / STMBs; the step of preparing the MAA / Strep-tag II / STMBs further comprises: mixing the pretreated STMBs coated with magnetic beads with the Strep-tag II solution to obtain Strep-tag II / STMB, adding methacrylamide to the Strep-tag II / STMB, and mixing to obtain MAA / Strep-tag II / STMBs. The N-terminus of Strep-tag II is modified with Maleimide; the sequence of the Strep-tag II is: Maleimide-Trp-Ser-His-Pro-Gln-Phe-Glu-Lys. The technical solution specifically defines that the N-terminus of Strep-tag II is modified with Maleimide because Strep-tag II relies on the carboxyl group on the Glu residue at its C-terminus to bind to Strep-Tactin. Therefore, after forming Strep-tag II / STMBs, the N-terminus of Strep-tag II is exposed to the outside and can react with the polymerized monomer MAA. Therefore, the technical solution modifies the N-terminus with Maleimide, and the nucleophilic nitrogen atom on MAA will attack the unsaturated carbonyl group of Maleimide, causing a Michael addition reaction, and then bind to Strep-tag II to form MAA / Strep-tag II / STMBs.

[0047] In a preferred embodiment, the treated magnetic beads STMBs are pretreated by the following method: take Strep-Tactin magnetic beads STMBs, wash with binding buffer containing Tris-HCl, NaCl, EDTA and pH 8.0 to complete the pretreatment; the particle size of the magnetic beads STMBs is 30-150μm, the ligand content is 6mg Strep-Tactin / mL gel, and the protein binding amount is 7Strep-tag II protein / mL gel. Further, the STMB used in this step is purchased from Suzhou Beaver Biomedical Engineering Co., Ltd., the magnetic beads have a particle size of 30-150μm, the ligand content is ~6mg Strep-Tactin / mL gel, and the protein binding amount is ~7Strep-tag II protein / mL gel. When purchased, the magnetic beads are provided in the form of a 10% (v / v) suspension, and the preservation solution is a 1-fold concentration of phosphate buffer, to which 0.1% Tween-20 and 0.05% NaN3 are added.

[0048] In a preferred embodiment, it also includes an Apt / Strep-tag II / imprinted hydrogel preparation step, which further includes: applying a mixture containing 1-ethyl-(3-dimethylaminopropyl) carbodiimide, N-hydroxysuccinimide, and 30-50nmol / L of an AChE specific binding aptamer to the surface of the Strep-tag II / hydrogel, followed by incubation, and allowing the AChE specific binding aptamer to specifically bind to the Strep-tag II site through a carboxyl-amine condensation reaction to obtain the Apt / Strep-tag II / imprinted hydrogel. This technical solution specifically limits the concentration of the AChE-specific binding aptamer. The reason is that when the concentration of the aptamer is lower than 30 nmol / L, the nanosheets in the generated AChE-Cu3(PO4)2 hybrid nanoflowers (HNFs) are arranged loosely, making it difficult to effectively form a clear flower-like structure; while when the concentration is within the range of 30-50 nmol / L, the arrangement of the nanosheets is more compact and orderly, thereby promoting the formation of a clear flower-like structure. This structural optimization strategy has a significant positive effect on improving the enzyme fixation efficiency and catalytic performance.

[0049] In a preferred embodiment, it also includes the step of preparing AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel, and the step of preparing AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel further includes: immersing the Apt / Strep-tag II / imprinted hydrogel in a mixed solution containing PBS, AChE solution and copper sulfate solution, and incubating to obtain AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel, i.e., a biosensor.

[0050] In a preferred embodiment, the sequence of the AChE-specific binding aptamer is:

[0051] 5′-NH2-TTTTT TTTTT TT GGTTG ACTGT AGCTC TGGCAGACGT AGTGT GAAGG TACC-3′.

[0052] Enzyme immobilization technology improves the stability and reusability of enzyme molecules by anchoring them on specific carriers. Hydrogels are considered to be ideal enzyme immobilization carriers due to their excellent biocompatibility and high water content. However, traditional embedding methods have problems such as low mass transfer efficiency, enzyme leakage and poor environmental adaptability. In response to the above problems, the present invention proposes a method for preparing the above-mentioned biosensor, which utilizes an innovative enzyme immobilization strategy, namely, surface imprinted hydrogel technology. The core of this strategy is to integrate substrate shielding technology, magnetic bead templates and Strep-Tag systems to form specific imprints on the surface of hydrogels, provide specific multivalent binding sites for acetylcholinesterase (AChE), and ensure high affinity interactions with AChE. These specific aptamers are completely exposed on the surface of the hydrogel, effectively improving the accessibility of AChE and successfully solving the mass transfer problem. In addition, the present invention also combines enzyme-mediated organic-inorganic hybrid nanoflower technology, which not only significantly increases the contact surface area between the enzyme and the substrate, but also greatly improves the activity and stability of the enzyme, effectively solving the problems of enzyme leakage and environmental adaptability.

[0053] The present invention innovatively proposes a new strategy for immobilizing enzymes using surface imprinted hydrogel technology, aiming to construct a biosensor that can efficiently identify AChE inhibitors. The core of this strategy lies in a sophisticated substrate shielding technology, which positions the magnetic bead template on a flat substrate to ensure that only the exposed surface of the magnetic beads participates in the polymerization reaction, while the rest is effectively shielded. When the magnetic beads are precisely removed, unique imprints are formed on the hydrogel surface. These imprints serve as multivalent binding platforms, providing a stable and adaptable anchoring environment for AChE-specific aptamers. The multivalent aptamers are fully exposed to the hydrogel surface, which not only greatly improves the accessibility of the recognition site, but also fundamentally solves the mass transfer barrier problem faced by hydrogel-immobilized enzymes. In order to further optimize the stability and environmental adaptability of the enzyme, the present invention also innovatively integrates enzyme-mediated organic-inorganic hybrid nanoflower self-assembly technology. In this technology, AChE enriched on the hydrogel surface induces copper phosphate crystals to self-assemble in an orderly manner to form AChE-copper phosphate hybrid nanoflowers (AChE-Cu3(PO4)2HNF). This hybrid nanoflower structure not only significantly increases the contact area between the enzyme and the substrate, promoting mass transfer efficiency, but also greatly improves the activity and stability of the enzyme.

[0054] The core of the above method is the integration of substrate shielding technology, magnetic bead templates and Strep-Tag system to precisely coordinate the polymerization reaction on the surface of magnetic beads. This process forms a unique imprint on the hydrogel surface after removing the magnetic beads, creating multivalent binding sites for AChE aptamers and ensuring high-affinity interaction with AChE. In addition, the integration of AChE-Cu3(PO4)2HNF into the hydrogel significantly increased the activity and stability of the enzyme, thereby improving the immobilization of AChE.

[0055] Another aspect of the present invention provides a biosensor prepared by the biosensor described in any of the above technical solutions. The biosensor can not only realize accurate identification of AChE inhibitors, but also can be reused multiple times and has good storage stability.

[0056] The present invention also provides the use of the above biosensor in detecting AChE inhibitors, including: using acetylthiocholine chloride as a specific substrate of AChE and oxidized 3,3',5,5'-tetramethylbenzidine as a color indicator to detect the AChE inhibitor.

[0057] In order to achieve accurate identification of AChE inhibitors, the present invention uses acetylthiocholine chloride (ATCl) as a specific substrate of AChE, and oxidized 3,3',5,5'-tetramethylbenzidine (oxTMB) as a color indicator. During the detection process, oxTMB is originally colorless, but is oxidized to blue under the action of hydrogen peroxide (H2O2) and heme (simulated peroxidase). Thiocholine (TCh) generated by AChE-catalyzed hydrolysis of ATCl is reducing and can reduce oxTMB to a colorless state, thereby intuitively reflecting the activity of AChE. When an AChE inhibitor is present, enzyme activity is inhibited, TCh generation is reduced, and the blue color of oxTMB deepens. This detection method based on color change can produce obvious visual differences even at extremely low inhibitor concentrations, showing high sensitivity and detection accuracy.

[0058] In a preferred embodiment, an activation process is also included: after the measurement is completed, the AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel is immersed in an acetylthiocholine chloride substrate solution, incubated at room temperature, and washed with ultrapure water to complete the activation.

[0059] In order to more clearly and in detail introduce the biosensor provided by the embodiments of the present invention, its preparation method and application, the following will be described in conjunction with specific embodiments.

[0060] Example 1

[0061] Preparation of AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel

[0062] Step 1: Pretreatment of STMBs

[0063] Take 100 μL of Strep-Tactin coated magnetic beads (STMBs), wash the beads three times with a binding buffer containing 100 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA and a pH of 8.0 to complete the pretreatment of STMBs.

[0064] (Note: STMB used in this step was purchased from Suzhou Beaver Biomedical Engineering Co., Ltd. The magnetic bead particle size is 30-150μm, the ligand content is ~6mg Strep-Tactin / mL gel, and the protein binding capacity is ~7Strep-tag II protein / mL gel. When purchased, the magnetic beads are provided in the form of a 10% (v / v) suspension, and the storage solution is a 1x concentration of phosphate buffer, to which 0.1% Tween-20 and 0.05% NaN3 are added.)

[0065] Step 2: Preparation of MAA / Strep-tag II / STMBs

[0066] The STMBs treated in step 1 were mixed with 1 mL of a 0.1 mg / mL Strep-tag II solution at 37°C for 1 hour by gentle rotation to promote the binding of Strep-tag II to Strep-Tactin on the surface of STMBs. Unbound Strep-tag II was then removed by rinsing with ultrapure water to obtain Strep-tag II / STMB. Next, 1 mL of 200 mmol / L methacrylamide (MAA) solution was added to Strep-tag II / STMB and mixed by rotation at 37°C for 2 hours to form MAA / Strep-tag II / STMBs.

[0067] (Note: The N-terminus of Strep-tag II used in this step is modified with maleimide. The sequence is: Maleimide-Trp-Ser-His-Pro-Gln-Phe-Glu-Lys.)

[0068] Step 3: Preparation of STMB / Strep-tag II / hydrogel

[0069] Take 100 μL of the MAA / Strep-tag II / STMBs suspension prepared in step 2 and drop it into the well of a cell culture plate with a diameter of 17 mm. Next, to ensure that the suspension can fully cover the bottom of the well, add 200 μL of ultrapure water. Then, through gentle shaking, MAA / Strep-tag II / STMBs are evenly and stably distributed at the bottom of the well. Next, fix a magnet under the well and use magnetic adsorption force to firmly fix the magnetic beads at the bottom of the well so that part of the surface of the magnetic beads is shielded by the bottom of the well.

[0070] Subsequently, the raw material solution required for the polymerization reaction was prepared: 2.4 g acrylamide, 0.064 g N,N'-methylenebisacrylamide (MBAA) and 0.060 g α,α'-azobisisobutylamidine dihydrochloride (AIBD) were dissolved in 8 mL ultrapure water and stirred evenly. Then, 400 μL of the raw material solution was slowly added dropwise to the wells of the cell culture plate.

[0071] Finally, the culture plate was placed in an environment of 50-55°C and incubated for 20-30 minutes to allow the components in the raw material solution to undergo free radical polymerization under the catalysis of AIBD, and MBAA served as a cross-linking agent to promote the formation of hydrogel.

[0072] After the gel is fully formed, gently remove the magnet and carefully peel the STMB / Strep-tag II / hydrogel complex from the culture plate well. Then, immerse the peeled complex in ultrapure water to allow it to fully swell to its maximum volume.

[0073] The key technical points in this step are:

[0074] The primary function of adding an additional 200 μL of ultrapure water is to ensure that the liquid fully covers the bottom of the well, promote the uniform distribution of the magnetic beads in the well, and avoid aggregation. Secondly, and more importantly, when the magnetic beads are fixed to the bottom of the well by the action of the magnet, a layer of water naturally forms above them. This layer of water plays a key interfacial isolation role when the subsequent raw material liquid is added, so that the raw material liquid does not directly touch the exposed surface of the magnetic beads, but first penetrates the water layer and contacts the magnetic beads in a gradual manner, thereby achieving a sustained release effect of the raw material. This mechanism of action helps to form a hydrogel layer with moderate hardness on the surface of the magnetic beads, creating favorable conditions for the subsequent easy elution of the magnetic beads from the hydrogel and the formation of surface imprints.

[0075] To verify the effectiveness of this technique, we compared the scanning electron microscopy images of STMB / Strep-tag II / hydrogels prepared with and without the addition of 200 μL of ultrapure water (e.g. Figure 1 , 2As shown). The results show that when ultrapure water is added, the hydrogel structure becomes looser, the pore size increases significantly, and the magnetic beads are clearly visible and mainly distributed on the surface of the hydrogel. This structure greatly facilitates the subsequent magnetic bead elution process and the formation of surface imprints. On the contrary, if ultrapure water is not added, the hydrogel structure is compact, the pore size decreases, and the magnetic beads are deeply embedded in it, with only a small amount of surface exposed, which makes the subsequent magnetic bead elution more difficult.

[0076] Step 4: Preparation of Strep-tag II / imprinted hydrogel

[0077] The STMB / Strep-tag II / hydrogel prepared in step 3 was placed in a solution containing 5 mL of 35 μmol / L desthiobiotin and incubated at 37°C for 1 hour with shaking. After the incubation, the STMBs in the solution were collected using magnetic separation technology, leaving a hydrogel with Strep-Tag II sites imprinted on the surface, namely Strep-Tag II / imprinted hydrogel. The scanning electron microscopy characterization image of Strep-Tag II / imprinted hydrogel is shown in Figure 2. Figure 3 As shown, the hydrogel surface is clean and free of magnetic beads after the magnetic beads are successfully removed.

[0078] Step 5: Preparation of Apt / Strep-tag II / Imprinted Hydrogel

[0079] A 2 mL mixture containing 30-50 nmol / L AChE-specific binding aptamer (Apt), 1.8 mM 1-ethyl-(3-dimethylaminopropyl) carbodiimide (EDC) and 1.5 mmol / L N-hydroxysuccinimide (NHS) was applied to the surface of the Strep-tag II / hydrogel prepared in step 4. Subsequently, the mixture was incubated at 37°C for 2 hours to promote the specific binding of Apt to the Strep-tag II site through the carboxyl-amine condensation reaction. After the reaction, the hydrogel was rinsed with water three times to remove unbound Apt, and finally the Apt / Strep-tag II / imprinted hydrogel was obtained.

[0080] The sequence of the aptamer is as follows:

[0081] 5′-NH2-TTTTT TTTTT TT GGTTG ACTGT AGCTC TGGCA GACGT AGTGT GAAGG TACC-3′

[0082] The core of this step is the concentration control of the aptamer (Apt). Specifically, Figure 4-7The effect of aptamers at different concentrations on the morphology of AChE-Cu3(PO4)2HNFs was demonstrated. When the concentration of the aptamer was lower than 30nmol / L, the nanosheets in the AChE-Cu3(PO4)2 hybrid nanoflowers (HNFs) generated in step 6 were arranged loosely, making it difficult to effectively form a clear flower-like structure; while when the concentration was in the range of 30 to 50nmol / L, the arrangement of the nanosheets was more compact and orderly, thus promoting the formation of a clear flower-like structure. This structural optimization strategy has a significant positive effect on improving the enzyme's immobilization efficiency and catalytic performance.

[0083] Step 6: Preparation of AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel

[0084] The Apt / Strep-tag II / imprinted hydrogel prepared in step 5 was immersed in a mixture containing 10 mL PBS, 1 mL 0.5 mg / mL AChE solution, and 40 μL 120 mmol / L copper sulfate (CuSO4) solution, and incubated at 25° C. for 72 hours. After the incubation period, AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel was obtained.

[0085] Example 2

[0086] Methods for identifying AChE inhibitors

[0087] Step 1: Preparation of colorimetric indicator

[0088] At pH 3, 1 μmol / L hemoglobin, 2 mmol / L hydrogen peroxide and 1.5 mmol / L 3,3',5,5'-tetramethylbenzidine (TMB) were incubated for 2 hours to prepare an oxidized TMB solution, which is a colorimetric indicator.

[0089] Step 2: Response of AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel to substrate

[0090] The AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel prepared in (1) was immersed in 2mL0.5mmol / L acetylthiocholine chloride (ATCl) substrate solution and reacted for 70 minutes. Afterwards, 200μL of the supernatant after the reaction was mixed with 200μL of the indicator. After 5 minutes, the color change was observed and the UV-visible absorption spectrum was measured. The change value of the absorption peak intensity at a wavelength of 650nm was recorded, which was the initial response of the AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel to the substrate.

[0091] Step 3: Identification of AChE inhibitors

[0092] The AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel prepared in (1) was immersed in the sample solution for 5 minutes. Then, 2mL of 0.5mmol / L ATCl substrate solution was added thereto and reacted for 70 minutes. Afterwards, 200μL of the supernatant after the reaction was mixed with 200μL of the indicator. After 5 minutes, the color change was observed and the UV-visible absorption spectrum was measured. The change in the absorption peak intensity at a wavelength of 650nm was recorded, which was the response of the AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel to the substrate after the sample acted.

[0093] The inhibition rate was calculated according to the following formula:

[0094] Inhibition rate (%) = [(initial response - response after interaction with sample) / initial response] × 100%

[0095] Finally, the presence of AChE inhibitors in the sample was determined based on the inhibition rate.

[0096] Example 3

[0097] Activation and Recycling of AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / Imprinted Hydrogel

[0098] Step 1: Activation of AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel

[0099] After the measurement, the AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel was immersed in 3.5mmol / L ATCl substrate solution and incubated at room temperature for 70 minutes, followed by washing with ultrapure water three times to complete the activation.

[0100] Step 2: Reuse of AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel

[0101] Immerse the AChE / Cu3(PO4)2-HNF@aptamer@nanogold@carbon paper activated in step (3) 1 into the sample solution for 5 minutes. Then, add 2mL of 0.5mmol / L ATCl substrate solution and react for 70 minutes. After that, take 200μL of the supernatant after the reaction and mix it with 200μL of the indicator. After 5 minutes, observe the color change and measure the UV-visible absorption spectrum. Record the change value of the absorption peak intensity at a wavelength of 650nm, and then calculate the inhibition rate. This completes one-time reuse.

[0102] Performance Testing

[0103] Attached are the experimental results:

[0104] (1) Recognition effect of AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel on AChE inhibitors

[0105] In order to verify the effectiveness of our prepared AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel in identifying AChE inhibitors, we selected galanthamine as a model inhibitor for verification. We exposed the composite hydrogel to different concentrations of galanthamine solution (ranging from 10nmol / L to 1mmol / L) for 5 minutes, and then detected their response to the substrate ATCl. Figure 8 The absorption spectrum and color of the solution change with the change of galanthamine concentration. As expected, the presence of the inhibitor galanthamine inhibits the activity of AChE, resulting in a decrease in the generation of TCh, which in turn reduces the reduction potential of oxTMB and causes the solution to gradually turn blue. The experimental results show that with the increase of galanthamine concentration, the blue color of the solution gradually deepens, and the characteristic absorption peak intensity of oxTMB also increases accordingly, which verifies our hypothesis.

[0106] To more precisely quantify this inhibitory trend, we calculated the inhibition rate of the colorimetric signal at different galantamine concentrations and plotted these data in a graph ( Fig. 9 ). In the chart, we use the inhibition rate as the vertical axis and the logarithm of the galanthamine concentration (Log value) as the horizontal axis. Data analysis shows that there is an obvious S-shaped curve relationship between the inhibition rate and the Log value of the galanthamine concentration. It is particularly noteworthy that in the low concentration range (<100nmol / L), the inhibition effect is relatively weak; when the concentration increases to between 100nmol / L and 1μmol / L, the inhibition effect increases sharply; after exceeding 1μmol / L, the growth of the inhibition rate tends to be flat, indicating that the inhibition of AChE has approached saturation.

[0107] In order to more accurately measure the inhibitory ability of the inhibitor, we used the half inhibitory concentration (IC 50 ) is a key indicator, which defines the inhibitor concentration required to achieve 50% inhibition. By performing a detailed linear regression analysis on data points close to 50% inhibition, we independently constructed a prediction model for the colorimetric detection mode: y = 0.0559x + 25.1931, R 2 Values ​​as high as 0.9948 (such as Fig. 9 Based on this model, we calculated the IC 50 The value was 0.443 μmol / L. Although there may be slight differences between the experimental conditions and those reported in the literature, these differences may affect the IC 50 Although the value of galantamine has a certain impact, our results still strongly prove that galantamine has a significant inhibitory effect on AChE in the micromolar concentration range. As a mainstream drug for the treatment of Alzheimer's disease, galantamine exhibits a low IC 50 The values ​​are consistent with its clinical therapeutic effect, further verifying its effectiveness as an AChE inhibitor.

[0108] (2) Reusability of AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel

[0109] We used 3.5 mM ATCl to activate the composite hydrogel and further evaluated its reusability. Fig.10 In the data shown, the composite hydrogel can still maintain more than 95% of its initial activity after five consecutive uses, which fully demonstrates its excellent reusability.

Claims

1. A method for preparing a biosensor, characterized in that: It includes STMB / Strep-tag II / hydrogel preparation steps, and Strep-tag II / imprinted hydrogel preparation steps; The STMB / Strep-tag II / hydrogel preparation step further comprises: Take the MAA / Strep-tag II / STMBs suspension and drop it into the well of the cell culture plate, then add ultrapure water, shake well to make the MAA / Strep-tag II / STMBs evenly and stably distributed at the bottom of the well, fix a magnet under the well, and use magnetic adsorption force to fix the MAA / Strep-tag II / STMBs at the bottom of the well, so that part of the surface of the MAA / Strep-tag II / STMBs is shielded by the bottom substrate of the well, and a water layer is formed above the MAA / Strep-tag II / STMBs; Dissolve acrylamide, N,N'-methylenebisacrylamide and α,α'-azobisisobutylamidine dihydrochloride in ultrapure water, stir evenly to obtain a polymerization raw material solution, and slowly drop the polymerization raw material solution into the wells of the cell culture plate; The wells of the cell culture plate are placed in an environment of 50-55° C. and incubated for 20-30 minutes to form a hydrogel complex. After the hydrogel complex is completely formed, the magnet is gently removed, and the hydrogel complex is peeled off from the cell culture plate. The peeled hydrogel complex is immersed in ultrapure water to fully swell to the maximum volume to obtain STMB / Strep-tag II / hydrogel; The preparation step of the Strep-tag II / imprinted hydrogel further includes: placing the STMB / Strep-tag II / hydrogel in a solution containing desthiobiotin, incubating with shaking, and collecting the STMBs in the solution using magnetic separation technology, leaving a hydrogel with Strep-TagⅡ sites imprinted on the surface, namely, Strep-Tag II / imprinted hydrogel.

2. The method for preparing a biosensor according to claim 1, characterized in that: It also includes a MAA / Strep-tag II / STMBs preparation step for preparing the MAA / Strep-tag II / STMBs; The MAA / Strep-tag II / STMBs preparation step further includes: mixing the pretreated magnetic bead-coated STMBs with the Strep-tag II solution to obtain Strep-tag II / STMB, adding methacrylamide to the Strep-tag II / STMB, and mixing to obtain MAA / Strep-tag II / STMBs.

3. The method for preparing a biosensor according to claim 2, characterized in that: The N-terminus of Strep-tag II is modified with Maleimide; the sequence of the Strep-tag II is: Maleimide-Trp-Ser-His-Pro-Gln-Phe-Glu-Lys.

4. The method for preparing a biosensor according to claim 2, characterized in that: The treated magnetic bead-coated STMBs are pretreated by the following method: taking Strep-Tactin-coated magnetic bead STMBs, washing them with a binding buffer containing Tris-HCl, NaCl, EDTA and a pH value of 8.0 to complete the pretreatment; the particle size of the magnetic bead-coated STMBs is 30-150 μm, the ligand content is 6 mg Strep-Tactin / mL gel, and the protein binding amount is 7 Strep-tag II protein / mL gel.

5. The method for preparing a biosensor according to claim 1, characterized in that: The method also includes an Apt / Strep-tag II / imprinted hydrogel preparation step, which further includes: applying a mixture containing 1-ethyl-(3-dimethylaminopropyl) carbodiimide, N-hydroxysuccinimide, and 30-50 nmol / L of an AChE specific binding aptamer to the surface of the Strep-tag II / hydrogel, followed by incubation, and allowing the AChE specific binding aptamer to specifically bind to the Strep-tag II site through a carboxyl-amine condensation reaction to obtain the Apt / Strep-tag II / imprinted hydrogel.

6. The method for preparing a biosensor according to claim 5, characterized in that: The method also includes a step of preparing an AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel, which further includes: immersing the Apt / Strep-tag II / imprinted hydrogel in a mixed solution containing PBS, an AChE solution and a copper sulfate solution, and incubating to obtain the AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel, i.e., a biosensor.

7. The method for preparing a biosensor according to claim 5, characterized in that: The sequence of the AChE specific binding aptamer is: 5′-NH2-TTTTT TTTTT TT GGTTG ACTGT AGCTC TGGCAGACGT AGTGT GAAGG TACC-3′.

8. A biosensor prepared according to the biosensor according to any one of claims 1 to 7.

9. Use of the biosensor according to claim 7 in detecting AChE inhibitors, characterized in that: include: Acetylthiocholine chloride was used as the specific substrate of AChE and oxidized 3,3',5,5'-tetramethylbenzidine was used as a color indicator to detect AChE inhibitors.

10. Use of the biosensor according to claim 9 in detecting AChE inhibitors, characterized in that: The method also includes an activation process: after the measurement is completed, the AChE-Cu3(PO4)2HNF / Apt / Strep-tag II / imprinted hydrogel is immersed in an acetylthiocholine chloride substrate solution, incubated at room temperature, and washed with ultrapure water to complete the activation.